Bilski v. Board of Medical Licensure and Discipline of the State of Delaware.

CourtSuperior Court of Delaware
DecidedJune 30, 2014
Docket13A-10-005
StatusPublished

This text of Bilski v. Board of Medical Licensure and Discipline of the State of Delaware. (Bilski v. Board of Medical Licensure and Discipline of the State of Delaware.) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bilski v. Board of Medical Licensure and Discipline of the State of Delaware., (Del. Ct. App. 2014).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

IN AND FOR NEW CASTLE COUNTY

WILLIAM F. BILSKI, D.O., ) Appellant, ) C. A. No.: N13A-10-005 VLM ) v. ) THE BOARD OF MEDICAL ) LICENSURE AND DISCIPLINE ) OF THE STATE OF DELAWARE, ) Appellee. )

OPINION

Submitted: March 26, 2014 Decided: June 30, 2014

Upon Consideration of Appellant’s Appeal of the Decision and Final Public Order of the Board of Medical Licensure and Discipline of the State of Delaware, AFFIRMED.

Victor F. Battaglia, Esquire, Biggs and Battaglia, 921 N. Orange Street, Wilmington, DE 19801, Attorney for Appellant.

Patricia Davis Oliva and Jennifer L. Singh, Deputy Attorneys General, Department of Justice, 102 W. Water Street, 3rd Floor, Dover, DE 19904, Attorneys for Appellee.

MEDINILLA, J. INTRODUCTION

A final order of the Board of Medical Licensure and Discipline of the State

of Delaware (“the Board”) found that Appellant, physician William Bilski D.O.,

(“Dr. Bilski”) acted unprofessionally and violated the Medical Practice Act,

pursuant to 24 Del. C. § 1731(b)(11). This is Dr. Bilski’s appeal pursuant to 24

Del. C. § 1736, 29 Del. C. § 10142, and Superior Court Civil Rule 72. This Court

finds that the Board’s order is supported by substantial evidence and free from

legal error. Therefore, the Board’s order is AFFIRMED.

FACTUAL AND PROCEDURAL HISTORY

On May 23, 2011, the Division of Professional Regulation (“Division”)

received a letter from a concerned parent regarding Dr. Bilski’s controlled

substance prescribing practices. The Division assigned an investigator, Ralph

Kemmerlin (“Kemmerlin”), who subpoenaed records and interviewed Dr. Bilski.

During the course of the investigation, Dr. Bilksi informed Kemmerlin of a second

patient whom Dr. Bilksi suspected had stolen a prescription pad. This prompted

Kemmerlin to open a second investigative complaint, wherein he subpoenaed

additional records and re-interviewed Dr. Bilksi regarding the second patient.

Following the investigation, on February 4, 2013, the Delaware Department

of Justice (“DOJ”) filed a disciplinary complaint with the Board alleging that Dr.

Bilski was guilty of unprofessional conduct. The DOJ specifically alleged that

1 beginning in 2009, while prescribing controlled substances to his patients, Dr.

Bilski failed to document the nature and intensity of his patient’s pain, current and

past pain treatments, underlying or coexisting diseases or conditions, the effects of

his patient’s pain on their physical and psychological functions, objectives to

measure success of controlled substance use over time, and discussions with

patients of the risks and benefits of using controlled substances. 1

The DOJ complaint asserted, in part, that Dr. Bilski’s conduct violated the

Federation of State Medical Boards’ Model Policy for the Use of Controlled

Substances (“Model Policy”), Board Regulation 31, 2 and alleged that his

misconduct constituted a pattern of negligence in the practice of medicine in

violation of 24 Del. C. § 1731(b)(11). On June 3, and 4, 2013, a Division of

Professional Regulation Hearing Officer (“Hearing Officer”) conducted an

evidentiary hearing pursuant to 29 Del. C. § 8735(v)(1)d.

The Hearing Officer heard evidence of deficient medical record keeping

practices related to two patients over the course of two years - collectively

resulting in the sum of more than sixty (60) deficient documentation practices.

1 Complaint at ¶7-10, 14-15, 22. 2 Board Regulation 31 was originally enacted as Board Regulation 30. See Complaint at ¶26e.1. 2 Specifically, from 2009 to 2011, as to the first patient, Dr. Bilski issued monthly

prescriptions including Oxycontin, Lortab, and Soma, for the treatment of pain. 3

Dr. Bilski consistently failed to document physical examinations, 4 any

comprehensive pain assessment, 5 or to indicate any treatment plan outline.6 His

medical records lacked any documentation evincing any doctor/patient discussions

of the risks associated with long-term use, misuse, or drug abuse, and of the pain

management medications as prescribed. 7 His medical records were unclear as to

when prescriptions were issued, when refills were ordered, 8 and at times failed to

identify which medication was being refilled. Dr. Bilski claimed that he was trying

to wean his patient off the medications, but nothing in the records documents such

a plan.9

The medical documentation of Dr. Bilski’s second patient is plagued with

similar deficiencies. Dr. Bilski prescribed Oxycodone and other controlled

substances to manage his patient’s pain from October 2009 to June 2011.10 During

that time, the evidence presented showed that Dr. Bilski did not document any

3 Appellee’s Answering Br. Appendix at 26 and 42. 4 Appellee’s Answering Br. Appendix at 19-21. 5 Appellee’s Answering Br. Appendix at 21-22. 6 Appellee’s Answering Br. Appendix at 24-25. 7 Appellee’s Answering Br. Appendix at 26-27 (Dr. Bilski claimed he did discuss the risks and benefits, but Kemmerlin did not find any “written evidence”). 8 Appellee’s Answering Br. Appendix at 31-32. 9 Appellee’s Answering Br. Appendix at 56-57. 10 Appellee’s Answering Br. Appendix at 37-38. 3 comprehensive pain evaluation, 11 offer alternative treatment options,12 or make an

appropriate referral to a pain management specialist. 13 He failed to screen for risk

of drug abuse,14 or speak to his patient regarding the risks associated with

prolonged use of controlled substances. 15 This patient’s records, just as with the

first patient’s, are ambiguous as to when medicines were prescribed and refilled. 16

In order to justify asking for an early refill, on several occasions, one patient

merely had to tell Dr. Bilski that prescriptions had only been partially refilled. 17

The testimony included that Dr. Bilski suspected one patient might have been

selling pills or forging prescriptions. 18 Regrettably, the records do not contain any

indication that Dr. Bilski ever did anything about it, including checking with the

pharmacy filling the prescription. 19

Dr. Bilski did not dispute the lack of documentation regarding his patients’

treatment plans. However, he argued for dismissal of the charges based on the

following: (1) Because Board Regulation 31 was not adopted until 2012, and after

the relevant period of conduct, he was not in violation of said regulation, (2) the

Model Policy could not legally set mandatory requirements, and (3) the complaint 11 Appellee’s Answering Br. Appendix at 38. 12 Appellee’s Answering Br. Appendix at 36. 13 Appellee’s Answering Br. Appendix at 36-37 14 Appellee’s Answering Br. Appendix at 37. 15 Appellee’s Answering Br. Appendix at 38. 16 See Appellee’s Answering Br. Appendix at 67-97. 17 Appellee’s Answering Br. Appendix at 89-93. 18 Appellee’s Answering Br. Appendix at 86. 19 Appellee’s Answering Br. Appendix at 89-93. 4 failed to give adequate notice of the charges. 20 These arguments were presented

and considered by the Hearing Officer as well as the Board, and essentially mirror

those put forth in this appeal.

Following approximately eleven hours of hearing, wherein Dr. Bilski was

represented by counsel, the Hearing Officer found a set of facts and made

recommendations to the Board. Specifically, the Hearing Officer issued a ninety

page recommendation on July 10, 2013 in which he recommended the Board find

Dr. Bilski’s conduct rose to the level of misconduct and violated 24 Del. C. §

1731(b)(11):

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mullane v. Central Hanover Bank & Trust Co.
339 U.S. 306 (Supreme Court, 1950)
Afroyim v. Rusk
387 U.S. 253 (Supreme Court, 1967)
Dambro v. Meyer
974 A.2d 121 (Supreme Court of Delaware, 2009)
General Motors Corporation v. Freeman
164 A.2d 686 (Supreme Court of Delaware, 1960)
Johnson v. Chrysler Corporation
213 A.2d 64 (Supreme Court of Delaware, 1965)
In Re Reardon
759 A.2d 568 (Supreme Court of Delaware, 2000)
Dallachiesa v. General Motors Corporation
140 A.2d 137 (Superior Court of Delaware, 1958)
Slawik v. State
480 A.2d 636 (Supreme Court of Delaware, 1984)
Turbitt v. Blue Hen Lines, Inc.
711 A.2d 1214 (Supreme Court of Delaware, 1998)
General Motors Corporation v. McNemar
202 A.2d 803 (Supreme Court of Delaware, 1964)
Oceanport Industries, Inc. v. Wilmington Stevedores, Inc.
636 A.2d 892 (Supreme Court of Delaware, 1994)
Reese v. Home Budget Center
619 A.2d 907 (Supreme Court of Delaware, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Bilski v. Board of Medical Licensure and Discipline of the State of Delaware., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bilski-v-board-of-medical-licensure-and-discipline-of-the-state-of-delsuperct-2014.